top of page
gradientForSurfBreak.png

Item List

Newswire EIN
CureMatch and xCures partner to revolutionize the standard for precision cancer treatment processes

CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine support for oncology, is proud to announce a partnership with xCures, Inc., to connect cancer patients and physicians with optimal investigational or approved therapies. CureMatch will leverage the xCures technology platform to create a comprehensive outline of a cancer patient’s medical history and further enhance its precision cancer treatment recommendation capabilities.

Recent Posts

Portfolio Company

Carlsmed.png

AI Used for Skin Cancer Checks at London Hospital
...

BBC

Portfolio Company

Carlsmed.png

CARTI Cancer Center Deploys DeepScribe's Ambient Operating System for Oncology ...

PR Newswire

Portfolio Company

Carlsmed.png

Ideem locks in $2.4M seed round for trust tech spinout driven by Toby Rush, star ...

Startland News

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page